Join
Live feed
·
PRReleasevia Quantisnow
Deciphera Pharmaceuticals Inc. logo

Deciphera Pharmaceuticals, Inc. Presents Updated Phase 1/2 Data for Vimseltinib in TGCT at the European Society for Medical Oncology (ESMO) Congress 2022

ByQuantisnow·Wall Street's wire, on your screen.
DCPH· Deciphera Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DCPH (Deciphera Pharmaceuticals Inc.) and more on Quantisnow.